Analysts expect Mesoblast Ltd to report revenue of 120.42 M for 2026, against a range of 115.63 M to 125.21 M. The most recent reported year, 2025, came in at 17.20 M, a 6.2% miss against the 18.34 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.50 M | 10.21 M | 7.50 M | 5.90 M | 17.20 M | - | - | ||
| High Estimate | 27.91 M | 14.59 M | 8.87 M | 7.71 M | 18.96 M | 125.21 M | 195.90 M | ||
| Low Estimate | 24.01 M | 12.02 M | 7.38 M | 6.41 M | 17.72 M | 115.63 M | 179.66 M | ||
| Consensus Estimate | 25.96 M | 13.30 M | 8.12 M | 7.06 M | 18.34 M | 120.42 M | 187.78 M |
Analysts expect Mesoblast Ltd to report earnings per share of -0.47 for 2026, against a range of -0.49 to -0.45. The most recent reported year, 2025, came in at -0.85, a 51.8% miss against the -0.56 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.55 | -1.33 | -1.05 | -0.89 | -0.85 | - | - | ||
| High Estimate | -1.17 | -0.96 | -1.06 | -0.51 | -0.53 | -0.45 | 0.00 | ||
| Low Estimate | -1.35 | -1.08 | -1.24 | -0.57 | -0.59 | -0.49 | 0.00 | ||
| Consensus Estimate | -1.26 | -1.02 | -1.15 | -0.54 | -0.56 | -0.47 | 0.00 |